Patents by Inventor Jasti Venkateswarlu

Jasti Venkateswarlu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220234990
    Abstract: Provided herein are methods and intermediates for making (1R,2R,5R)-5-amino-2-methylcyclohexanol hydrochloride, which are useful for the preparation of compounds useful for the treatment of a disease, disorder, or condition associated with the JNK pathway.
    Type: Application
    Filed: November 3, 2021
    Publication date: July 28, 2022
    Inventors: Terrence Joseph CONNOLLY, Hon-Wah MAN, Periyandi NAGARAJAN, Chinnapillai RAJENDIRAN, Jasti VENKATESWARLU
  • Patent number: 10774033
    Abstract: Provided herein are methods and intermediates for making (1R,2R,5R)-5-amino-2-methylcyclohexanol hydrochloride, which are useful for the preparation of compounds useful for the treatment of a disease, disorder, or condition associated with the JNK pathway.
    Type: Grant
    Filed: January 28, 2019
    Date of Patent: September 15, 2020
    Assignee: Celgene Corporation
    Inventors: Terrence Joseph Connolly, Hon-Wah Man, Periyandi Nagarajan, Chinnapillai Rajendiran, Jasti Venkateswarlu
  • Publication number: 20190152893
    Abstract: Provided herein are methods and intermediates for making (1R,2R,5R)-5-amino-2-methylcyclohexanol hydrochloride, which are useful for the preparation of compounds useful for the treatment of a disease, disorder, or condition associated with the JNK pathway.
    Type: Application
    Filed: January 28, 2019
    Publication date: May 23, 2019
    Inventors: Terrence Joseph CONNOLLY, Hon-Wah MAN, Periyandi NAGARAJAN, Chinnapillai RAJENDIRAN, Jasti VENKATESWARLU
  • Patent number: 10252981
    Abstract: Provided herein are methods and intermediates for making (1R,2R,5R)-5-amino-2-methylcyclohexanol hydrochloride, which are useful for the preparation of compounds useful for the treatment of a disease, disorder, or condition associated with the JNK pathway.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: April 9, 2019
    Assignee: Celgene Corporation
    Inventors: Terrence Joseph Connolly, Hon-Wah Man, Periyandi Nagarajan, Chinnapillai Rajendiran, Jasti Venkateswarlu
  • Publication number: 20180215700
    Abstract: Provided herein are methods and intermediates for making (1R,2R,5R)-5-amino-2-methylcyclohexanol hydrochloride, which are useful for the preparation of compounds useful for the treatment of a disease, disorder, or condition associated with the JNK pathway.
    Type: Application
    Filed: July 22, 2016
    Publication date: August 2, 2018
    Inventors: Terrence Joseph CONNOLLY, Hon-Wah MAN, Periyandi NAGARAJAN, Chinnapillai RAJENDIRAN, Jasti VENKATESWARLU
  • Patent number: 7388024
    Abstract: The present invention provides indeno[2,1a]indene and isoindolo[2,1-a]indole derivatives of the Formula I, its salts and its stereoisomers, wherein X, R1, R2, R3, R4, R6, R7, R8, R9, R11, R12, R13 and R14 are as described in the specification. The invention also provides a method to prepare the compound of formula I, pharmaceutical composition containing such compounds, and method to manufacture a medicament. These compounds are useful in the treatment of various CNS disorders, hematological disorders, eating disorders, diseases associated with pain, respiratory diseases, genito-urological disorders, cardio vascular diseases and cancer.
    Type: Grant
    Filed: June 29, 2006
    Date of Patent: June 17, 2008
    Assignee: Suven Life Sciences Limited
    Inventors: Jasti Venkateswarlu, Satya Nirogi Ramakrishna Venkata, Sastri Kambhampati Rama, Shreekrishna Shirsath Vikas, Kandikere Vishwottam Nagaraj
  • Patent number: 7385072
    Abstract: The invention disclosed in this application relates to an improved process for the preparation of Entacapone. In one embodiment the process involves: (i) reacting a 3-alkoxy-4-hydroxy-5-nitrobenzadehyde with N,N-diethylaminocyanoacetamide in the presence of a mild acid catalyst and a solvent, to provide a 3-O-alkylated Entacapone, and treating the 3-O-alkylated Entacapone with an acid catalyst in the presence of an organic base to provide Entacapone.
    Type: Grant
    Filed: June 29, 2006
    Date of Patent: June 10, 2008
    Assignee: Suven Life Sciences
    Inventors: Jasti Venkateswarlu, Arava Veera Reddy, Chinnapillai Rajendiran, Samjuddin Md Md
  • Publication number: 20070060767
    Abstract: The invention disclosed in this application relates to an improved process for the preparation of Entacapone. In one embodiment the process involves: (i) reacting a 3-alkoxy-4-hydroxy-5-nitrobenzadehyde with N,N-diethylaminocyanoacetamide in the presence of a mild acid catalyst and a solvent, to provide a 3-O-alkylated Entacapone, and treating the 3-O-alkylated Entacapone with an acid catalyst in the presence of an organic base to provide Entacapone.
    Type: Application
    Filed: June 29, 2006
    Publication date: March 15, 2007
    Inventors: Jasti Venkateswarlu, Arava Reddy, Chinnapillai Rajendiran, Samjuddin Md
  • Publication number: 20070054946
    Abstract: The present invention provides indeno[2,1a]indene and isoindolo[2,1-a]indole derivatives of the Formula I, its salts and its stereoisomers, wherein X, R1, R2, R3, R4, R6, R7, R8, R9, R11, R12, R13 and R14 are as described in the specification. The invention also provides a method to prepare the compound of formula I, pharmaceutical composition containing such compounds, and method to manufacture a medicament. These compounds are useful in the treatment of various CNS disorders, hematological disorders, eating disorders, diseases associated with pain, respiratory diseases, genito-urological disorders, cardio vascular diseases and cancer.
    Type: Application
    Filed: June 29, 2006
    Publication date: March 8, 2007
    Inventors: Jasti Venkateswarlu, Satya Venkata, Sastri Rama, Shreekrishna Vikas, Kandikere Nagaraj